SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ranbaxy venture wins $133-m HIV drug supply order in S. Africa

21 Dec 2010 Evaluate

Ranbaxy Laboratories South Africa-based joint venture, Sonke Pharmaceuticals, has won Rand $133 million order in that country for supplying anti-retroviral (ARV) drugs for prevention and treatment of AIDS over the next two years.

Sonke Pharmaceuticals is a joint venture between Ranbaxy Pharmaceuticals and Community Investment Holding is the second largest local supplier of generic ARV medication in South Africa. The medicines will be manufactured in South Africa and at Ranbaxy facilities in India.crackcrack

Peers
Company Name CMP
Sun Pharma Inds. 1823.75
Dr. Reddys Lab 1267.35
Cipla 1356.65
Zydus Lifesciences 1074.35
Lupin 2328.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: